20 employees
Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.
2007
$22M
from 1 investors over 1 rounds
Metamark Genetics raised $22M on August 13, 2010
Investors: Perseus